Top Markets
#1 ADO Protocol ADO Protocol +328.67%
#2 Tutorial Tutorial +67.51%
#3 Nockchain Nockchain +53.68%
#4 GoPlus Security GoPlus Security +52.39%
#5 Starpower Starpower +36.40%
#6 The Black Bull The Black Bull +35.69%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.31%
#8 GAIB AID GAIB AID +24.67%
#9 Verus Coin Verus Coin +16.89%
#10 Casper Network Casper Network +15.75%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Traws Pharma, Inc. Traws Pharma, Inc.

Traws Pharma, Inc.

TRAW
Rank in Stocks #33167
Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage,... Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat both respiratory viral infections and various forms of cancer. Its pipeline includes experimental treatments specifically designed to overcome drug resistance in influenza and COVID-19. These promising candidates include TRX01 (travatrelvir), an Mpro/3CL inhibitor currently undergoing development for COVID-19, and TRX100 (viroxavir), an endonuclease inhibitor advancing through trials for pandemic influenza. Additionally, Traws Pharma's oncology portfolio features narazaciclib, a multi-kinase CDK4/6 inhibitor. This compound is presently in Phase 1/2 clinical trials in cancer patients, being evaluated both independently and in conjunction with letrozole, with the goal of establishing the recommended Phase 2 dosage for future work in endometrial cancer. The company is also investigating oral rigosertib, exploring its potential as a standalone therapy or in combination regimens across diverse cancer types. Originally established in 1998 as Onconova Therapeutics, Inc., the company officially adopted its current name, Traws Pharma, Inc., in April 2024. Its corporate headquarters are located in Newtown, Pennsylvania.
Share Price
$0.5457
Market Cap
$8.31M
Change (1 day)
-4.43%
Change (1 year)
-63.86%
Country
US
Trade Traws Pharma, Inc. (TRAW)

Category

Healthcare
Stock price history for Traws Pharma, Inc. (TRAW)
Highest end of day price: $0.55 on 2026-08-01

Lowest end of day price: $1.18M on 2013-07-01
Stock price history of Traws Pharma, Inc. from 2013 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -7.87%
2025 -73.19%
2024 -62.45%
2023 -1.12%
2022 -73.33%
2021 -51.96%
2020 16.11%
2019 -88.57%
2018 -87.09%
2017 -39.73%
2016 -78.39%
2015 -71.56%
2014 -71.82%
2013 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $514.52 30.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $986.61 50.90%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 7.19%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $255.50 13.38%
BE